Comparison of cancer incidence between new glargine and NPH users (Intent-to-Treat Analysis).

CI, confidence interval; HR, hazard ratio. Note: Unadjusted HR and 95% CI were obtained from a Cox proportional hazards model adjusting for treatment only. Adjusted HR and 95% CI were obtained from a Cox proportional hazards model that adjusted for all variables listed in table 1 using inverse probability of treatment weights. Patients were followed until the first occurrence of one of the following events: the patient developed cancer, death, the study ended, or one year after the patient’s last visit in the database.Comparison of cancer incidence between new glargine and NPH users (Intent-to-Treat Analysis).